BofA Securities Downgrades National Health Investors to Underperform From Buy, Sets $67 Target
BofA Securities downgraded National Health Investors to Underperform from Buy and set a $67 price target.
BofA Securities downgraded National Health Investors to Underperform from Buy and set a $67 price target.